CompletedPhase 2NCT03275818

Trial of Nab-paclitaxel in Patients With Desmoid Tumors and Multiply Relapsed/Refractory Desmoplastic Small Round Cell Tumors and Ewing Sarcoma

Studying Desmoid tumor

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Grupo Espanol de Investigacion en Sarcomas
Principal Investigator
Javier Martin Broto, MD
Hospitales Universitarios Virgen del Rocío
Intervention
nab paclitaxel(drug)
Enrollment
69 enrolled
Eligibility
80 years · All sexes
Timeline
20172021

Study locations (7)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03275818 on ClinicalTrials.gov

Other trials for Desmoid tumor

Additional recruiting or active studies for the same condition.

See all trials for Desmoid tumor

← Back to all trials